Toumaz Technology and Imperial College London In Landmark Clinical Trial Of Sensium™-Enabled Digital Plaster

November 2, 2009 by neondrum

Toumaz Technology Limited, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions and wholly owned subsidiary of Toumaz Holdings (AIM: TMZ.L), today announces that it has begun clinical trials of its Sensium™ “digital plaster” wireless body monitor. The trial of the ultra-low power, ultra-small size body monitoring system is being conducted by a specialist clinical research team at Imperial College London. The study, which is being funded by global healthcare corporation CareFusion (a recent spin-out of Cardinal Health) and conducted at St Mary’s Hospital (part of Imperial College Healthcare NHS Trust) is expected to demonstrate the high quality physiological data that can be continuously acquired by wireless, unobtrusive Sensium-enabled devices. Initial results are expected by the end of December this year.
For more information read the full news release here:
http://www.neondrum.com/public/public_release.php?id=203

Permalink